يبحث (أخبار)

Innocare's Next-Generation Trki Zurletrectinib Receives Priority Review For The Treatment Of Pediatric Patients With Solid Tumors In China

health top

(MENAFN - GlobeNewsWire - Nasdaq) BEIJING, March 01, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969), a leading biopharmaceutical company for the treatment of cancer and autoimmune diseases, ...
2026-03-01 21:15:57